The US Supreme Court has rejected Bayer's bid to dismiss legal claims by customers who say its weedkiller causes cancer, as the German company seeks to avoid potentially billions of dollars in damages.
The justices turned away a Bayer appeal's on Tuesday and left in place a lower court decision that upheld $25m in damages awarded to California resident Edwin Hardeman, a user of its product Roundup, who blamed his cancer on the pharmaceutical and chemical giant's glyphosate-based weedkillers.
The Supreme Court's ruling dealt a blow to Bayer as the company manoeuvres to limit its legal liability in thousands of cases. The justices have a second Bayer petition pending on a related issue that they could act upon in the coming weeks.
Roundup-related lawsuits have dogged Bayer since it acquired the brand as part of its $63bn purchase of agricultural seeds and pesticides maker Monsanto in 2018.
[...] The lawsuits against Bayer have said the company should have warned customers of the alleged cancer risk.
[...] Bayer plans to replace glyphosate in weedkillers for the US residential market of non-professional gardeners with other active ingredients.